Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4611]

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma

ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma

ASH 2020: Researchers test CRISPR in blood disorders and extend CAR-T therapy to benefit more patients

ASH 2020: Researchers test CRISPR in blood disorders and extend CAR-T therapy to benefit more patients

ASH 2020: Donor stem cell transplant shown to improve survival in older patients with MDS

ASH 2020: Donor stem cell transplant shown to improve survival in older patients with MDS

Huntsman Cancer Institute researchers identify promising drug combination for melanoma

Huntsman Cancer Institute researchers identify promising drug combination for melanoma

Genetically engineered T cells could lead to therapies for autoimmune diseases

Genetically engineered T cells could lead to therapies for autoimmune diseases

New map provides scientists with head start on how to destroy cancer-related enzymes

New map provides scientists with head start on how to destroy cancer-related enzymes

Stress hormones can reawaken sleeping tumour cells, raising risk of cancer recurrence

Stress hormones can reawaken sleeping tumour cells, raising risk of cancer recurrence

IU researchers publish first article dedicated to Hoosier youth's donated tumour

IU researchers publish first article dedicated to Hoosier youth's donated tumour

FDA approves pralsetinib for RET-altered thyroid cancers

FDA approves pralsetinib for RET-altered thyroid cancers

More from ecancer